![Hims & Hers shares plunge 12% amid allegations of GLP-1 drug sourcing from ‘shady supplier’](https://images.fastcompany.com/image/upload/w_1280,q_auto,f_auto,fl_lossy/wp-cms-2/2024/06/p-91149075-hims-and-hers-stock-fall-june-28-2024.jpg)
Hims & Hers shares plunge 12% amid allegations of GLP-1 drug sourcing from ‘shady supplier’
Fast CompanyRoughly a month after announcing that it would offer GLP-1 injectable weight-loss drugs comparable to the popular drugs Ozempic and Monjaro, Hims & Hers Health shares are taking a beating after a new report criticized those offerings, saying that …